1. Home
  2. EDSA vs XTKG Comparison

EDSA vs XTKG Comparison

Compare EDSA & XTKG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EDSA
  • XTKG
  • Stock Information
  • Founded
  • EDSA 2015
  • XTKG 1997
  • Country
  • EDSA Canada
  • XTKG Singapore
  • Employees
  • EDSA N/A
  • XTKG N/A
  • Industry
  • EDSA Biotechnology: Pharmaceutical Preparations
  • XTKG
  • Sector
  • EDSA Health Care
  • XTKG
  • Exchange
  • EDSA Nasdaq
  • XTKG NYSE
  • Market Cap
  • EDSA 13.8M
  • XTKG 16.3M
  • IPO Year
  • EDSA N/A
  • XTKG 2019
  • Fundamental
  • Price
  • EDSA $2.05
  • XTKG $1.52
  • Analyst Decision
  • EDSA Strong Buy
  • XTKG
  • Analyst Count
  • EDSA 2
  • XTKG 0
  • Target Price
  • EDSA $13.00
  • XTKG N/A
  • AVG Volume (30 Days)
  • EDSA 33.4K
  • XTKG 107.1K
  • Earning Date
  • EDSA 08-08-2025
  • XTKG 07-07-2025
  • Dividend Yield
  • EDSA N/A
  • XTKG N/A
  • EPS Growth
  • EDSA N/A
  • XTKG N/A
  • EPS
  • EDSA N/A
  • XTKG N/A
  • Revenue
  • EDSA N/A
  • XTKG $11,611,442.00
  • Revenue This Year
  • EDSA N/A
  • XTKG N/A
  • Revenue Next Year
  • EDSA N/A
  • XTKG N/A
  • P/E Ratio
  • EDSA N/A
  • XTKG N/A
  • Revenue Growth
  • EDSA N/A
  • XTKG N/A
  • 52 Week Low
  • EDSA $1.55
  • XTKG $0.53
  • 52 Week High
  • EDSA $5.59
  • XTKG $11.60
  • Technical
  • Relative Strength Index (RSI)
  • EDSA 52.89
  • XTKG 50.52
  • Support Level
  • EDSA $1.91
  • XTKG $1.25
  • Resistance Level
  • EDSA $2.14
  • XTKG $2.24
  • Average True Range (ATR)
  • EDSA 0.12
  • XTKG 0.25
  • MACD
  • EDSA 0.02
  • XTKG -0.01
  • Stochastic Oscillator
  • EDSA 64.52
  • XTKG 27.27

About EDSA Edesa Biotech Inc.

Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.

About XTKG X3 HOLDINGS CO LTD

X3 Holdings Co Ltd is company which is responsible for globally providing of Technology Solutions and Services across Diverse Industries. It generates revenue from service lines: Application development services; Consulting and technical support services; Subscription services; Trading; and Others, of which maximum revenue is derived from Application development services. Geographically, all of the company's revenue is derived from PRC.

Share on Social Networks: